Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Vanc set to launch INSTI HIV rapid point-of-care test

Nov. 27, 2017

Novel IDO-1 inhibitors discovered at GlaxoSmithKline

Nov. 27, 2017

FDA approves Juluca, the first two-drug regimen for treatment of HIV-1

Nov. 22, 2017

Phase I results for AAV1 vectored immunoprophylaxis for HIV

Nov. 20, 2017

Viiv conducts first-in-human study of maturation inhibitor GSK-3640254

Nov. 9, 2017

Fostemsavir reduces HIV-1 viral load in heavily treatment-experienced patients

Oct. 30, 2017

Immunocore presents constructs for treating HIV infection and AIDS

Oct. 25, 2017

Population Council initiates phase I study of griffithsin gel for HIV prevention

Oct. 23, 2017

EC approves Symtuza for HIV-1 in adolescents and adults, NDA filed in U.S.

Sep. 26, 2017

Grant supports IBBR's development of multispecific antibody as therapeutic for HIV

Sep. 6, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...